Sign inJoin waitlistJoin the waitlist

CS

Christopher Stokoe

Physician · Texas Oncology

Credentials: · · ·

History

Texas Oncology
Present

Baylor University Medical Center
1999–2001
Baylor University Medical Center
2000–2001
Obstetrics and Gynecology
Baylor University Medical Center
1997–2001
Internal Medicine
Baylor University Medical Center
1994–1997
Baylor Medical Center
1996–1997
University of Texas Medical Branch at Galveston School of Medicine
1992–1996
Orthopaedic Surgery
University of Texas Medical Branch Hospitals
1991–1996

Research

NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and…
Journal of Clinical Oncology · 2020 · 348 citations
Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study
The Lancet Oncology · 2013 · 106 citations
Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine
Clinical Cancer Research · 2015 · 50 citations

JO
Joyce O'Shaughnessy
4 papers
DP
Devchand Paul
3 papers
FH
Frankie Holmes
3 papers
JP
John Pippen
3 papers
DL
Deborah Lindquist
2 papers
JB
Joanne Blum
2 papers
LK
Lea Krekow
2 papers
NR
Nicholas Robert
2 papers
SS
Scot Sedlacek
2 papers
SV
Svetislava Vukelja
2 papers
AF
Anne Favret
1 paper
Anthony Elias
1 paper